blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3516045

EP3516045 - METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  14.08.2020
Database last updated on 16.11.2024
FormerRequest for examination was made
Status updated on  28.06.2019
FormerThe international publication has been made
Status updated on  30.03.2018
Formerunknown
Status updated on  25.10.2017
Most recent event   Tooltip28.09.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
The United States of America, as represented by The Secretary, Department of Health and Human Services
Office of Technology Transfer
National Institutes of Health
6011 Executive Boulevard, Suite 325
MSC 7660
Bethesda, MD 20892-7660 / US
[2019/31]
Inventor(s)01 / CAFRI, Gal
305 Congressional Lane
Rockville Maryland 20852 / US
02 / ROBBINS, Paul F.
7907 Glendale Road
Chevy Chase Maryland 20815 / US
03 / GARTNER, Jared J.
10112 Tobacco Leaf Lane
Gaithersburg Maryland 20882 / US
04 / ROSENBERG, Steven A.
10104 Iron Gate Road
Potomac Maryland 20854 / US
 [2019/31]
Representative(s)Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[N/P]
Former [2019/31]Huenges, Martin
Maiwald Patentanwalts- und
Rechtsanwaltsgesellschaft mbH
Elisenhof
Elisenstraße 3
80335 München / DE
Application number, filing date17784443.818.09.2017
[2019/31]
WO2017US51981
Priority number, dateUS201662398963P23.09.2016         Original published format: US 201662398963 P
[2019/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018057447
Date:29.03.2018
Language:EN
[2018/13]
Type: A1 Application with search report 
No.:EP3516045
Date:31.07.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 29.03.2018 takes the place of the publication of the European patent application.
[2019/31]
Search report(s)International search report - published on:EP29.03.2018
ClassificationIPC:C12N5/0784
[2019/31]
CPC:
C12N5/0639 (EP,US); A61K39/4615 (EP,US); A61K39/4622 (EP,US);
A61K39/464401 (EP,US); A61K39/464456 (EP,US); A61K39/464486 (EP,US);
A61K39/464492 (EP,US); A61K39/464838 (EP,US); C12N2501/02 (EP,US);
C12N2501/05 (EP); C12N2501/052 (EP,US); C12N2501/22 (EP,US);
C12N2501/2301 (EP,US); C12N2501/2304 (EP,US); C12N2501/2306 (EP,US);
C12N2501/24 (EP,US); C12N2501/25 (EP,US); C12N2501/52 (EP,US);
C12N2501/999 (EP,US); C12N2502/11 (EP); C12N2502/1114 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/31]
TitleGerman:VERFAHREN ZUR HERSTELLUNG EINER ISOLIERTEN POPULATION VON DENDRITISCHEN ZELLEN UND VERFAHREN ZUR BEHANDLUNG VON KREBS DAMIT[2019/31]
English:METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME[2019/31]
French:PROCÉDÉS DE PRÉPARATION D'UNE POPULATION ISOLÉE DE CELLULES DENDRITIQUES ET MÉTHODES DE TRAITEMENT DU CANCER AU MOYEN DE LADITE POPULATION ISOLÉE[2019/31]
Entry into regional phase21.03.2019National basic fee paid 
21.03.2019Designation fee(s) paid 
21.03.2019Examination fee paid 
Examination procedure21.03.2019Examination requested  [2019/31]
21.03.2019Date on which the examining division has become responsible
11.11.2019Amendment by applicant (claims and/or description)
17.08.2020Despatch of a communication from the examining division (Time limit: M04)
18.12.2020Reply to a communication from the examining division
17.08.2021Despatch of a communication from the examining division (Time limit: M06)
04.02.2022Reply to a communication from the examining division
02.11.2023Despatch of a communication from the examining division (Time limit: M04)
01.03.2024Reply to a communication from the examining division
Fees paidRenewal fee
27.09.2019Renewal fee patent year 03
28.09.2020Renewal fee patent year 04
27.09.2021Renewal fee patent year 05
27.09.2022Renewal fee patent year 06
27.09.2023Renewal fee patent year 07
27.09.2024Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XYI]WO03020889  (3M INNOVATIVE PROPERTIES CO [US]);
 [XYI]WO2004072262  (NORTHWEST BIOTHERAPEUTICS INC [US], et al);
 [XYI]WO2011143656  (GEN HOSPITAL CORP [US], et al);
 [XYI]WO2016040900  (UNIV WASHINGTON [US]);
ExaminationWO2011098516
by applicantUS7820174
 US8216565
 US8465743
 US2013274203
 US2014037628
 US8785601
 US2014274909
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.